Interim 2022 results: oodles of progress
Destiny reported its H1 2022 financial results and provided an update on its pipeline progress. We...
Read moreStaying the course
First half FY 22 results mirrored the July trading update with revenue of £50.6m +14.5%YoY close to...
Read moreMaking p38 MAP kinase inhibition viable
The inhibition of the validated drug target p38 MAP kinase has been shown by many big...
Read moreDivisional growth on track, group scaling up
The interim results were a strong reminder that operationally RQIH remains on track to meet its...
Read moreQ3 update: Positive outlook in uncertain times
Benchmark’s results for the FY22 Q3 (April-June) period showed robust sales plus adjusted EBITDA...
Read more
First corner turned
After a period of sub-optimal performance, Gattaca - the UK's largest specialist engineering/tech...
Read moreSolid as a rock
Vp – a specialist equipment rental firm - indicated last Tuesday that it remained on track to meet...
Read moreStrong operational progress to give perspective
Only two months ago shareholders saw sufficient potential upside to reject a bid at c. 128p...
Read moreStake in 8AM acquired, net inflows solid
Tatton has now concluded the acquisition of 50% of 8AM Global Limited (8AM) for a total...
Read morePositive AGM Statement
RUA Life Sciences’ AGM statement led with an update on its two revenue-generating businesses for...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
